Four Bloggers Who Promoted Japan’s Popular Painkiller “EVE”
Some Ingredients in the Products Classified as Psychotropic Substances in South Korea
Constitutional Court: "Insufficient Evidence They Knew the Products Contained the Ingredient"; Deferred Prosecution Overturned

Four bloggers who received deferred prosecution for allegedly violating the Narcotics Control Act after introducing Japan's popular painkiller EVE on their blogs have been granted relief by the Constitutional Court. The court found insufficient evidence to conclude that they knew the product contained an ingredient classified as a psychotropic substance in South Korea when they promoted it.


Four bloggers who received suspended indictments on suspicion of violating the Narcotics Control Act after introducing Japan’s popular painkiller EVE on their blogs received relief from the Constitutional Court. Getty Images

Four bloggers who received suspended indictments on suspicion of violating the Narcotics Control Act after introducing Japan’s popular painkiller EVE on their blogs received relief from the Constitutional Court. Getty Images

View original image

According to the Official Gazette and other sources on November 18, the Constitutional Court ruled unanimously on October 22 to grant the petitions filed by four people, including A, seeking to overturn their deferred prosecution dispositions.


From 2022 to 2024, A and the others posted advertisements on Naver blogs featuring reviews of Japan's EVE painkillers, product introductions, and information on where to buy them. An investigation found that some had joined product review groups recruited by companies, received products for free, and written promotional posts.


The issue was an ingredient in the products. Some EVE products sold by Japanese pharmaceutical company SSP contain an ingredient called allylisopropylacetylurea. In South Korea, the ingredient is classified as a psychotropic substance and regulated under the Narcotics Control Act.

EVE Quick, a Japanese pain reliever. Samurai Drugstore.

EVE Quick, a Japanese pain reliever. Samurai Drugstore.

View original image

EVE is a brand of painkillers launched by Japan's SSP in 1985. Of the five types on the market at the time of reporting in April 2025, four were reported to contain the ingredient. In Japan, they are sold as over-the-counter painkillers, but products containing the ingredient are prohibited from being brought into South Korea.


In October 2025, prosecutors issued deferred prosecution dispositions, determining that A and the others' online posts providing information on where to buy the products constituted advertisements encouraging the handling of narcotics. Deferred prosecution is a disposition in which prosecutors decide not to indict someone, despite finding the criminal allegations substantiated, after considering various circumstances.


A and the others, however, argued that they did not know the products contained a psychotropic substance. They filed a constitutional complaint, saying it was unjust for prosecutors to find the allegations substantiated without sufficiently investigating whether they had acted intentionally.

A view of the Constitutional Court in Jongno-gu, Seoul. Yonhap News

A view of the Constitutional Court in Jongno-gu, Seoul. Yonhap News

View original image

The Constitutional Court ruled in their favor. It acknowledged that they had promoted the products on their blogs, but found insufficient evidence to conclude that they had also known at the time that the products contained a psychotropic substance.


In particular, the Korea Customs Service announced plans to step up crackdowns on overseas medicines containing narcotic substances in March 2025. The following month, media reports revealed that the importation of EVE painkillers into South Korea had been blocked. Both events occurred after A and the others had written their advertising posts.


The Constitutional Court also considered that many posts recommending or promoting the use of EVE painkillers had been published online at the time. The fact that some bloggers had been selected for product review groups, received products for free, and written posts according to companies' instructions was not, on its own, enough to conclude that they had accepted the possibility that their actions were illegal, amounting to "dolus eventualis."


The Constitutional Court therefore criticized prosecutors for concluding that the allegations were substantiated without conducting further investigations into whether the bloggers had acted intentionally. It ruled that the petitioners' rights to equality and the pursuit of happiness had been violated, stating, "The deferred prosecution dispositions, issued on the premise that the allegations of violating the Narcotics Control Act were substantiated, resulted from arbitrary assessment of evidence, insufficient investigation, and errors in the application of the law."


This ruling does not mean that bringing overseas medicines containing narcotic substances into South Korea or advertising them is permitted. The Constitutional Court overturned the deferred prosecution dispositions because intent to promote the products with knowledge that they contained the ingredient had not been sufficiently established.



Meanwhile, cases in which people bring overseas medicines into South Korea without knowing that they contain regulated ingredients are also reportedly common. According to the Korea Customs Service, the volume of illegal medicines containing narcotic substances brought into the country rose about 43-fold, from 885g in 2020 to 37,688g in 2024. A Korea Customs Service official has said that people frequently bring in overseas medicines without properly checking their ingredients.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing